New Delhi, April 5 -- US President Donald Trump has announced a sweeping 100 per cent tariff on select pharmaceutical imports, a move that comes shortly after a Jefferies report flagged the possibility of such measures, while maintaining a relatively constructive stance on Indian generic drug makers.

In its April 2 report, Jefferies had noted that "the Trump administration is preparing to impose tariffs of 100 per cent on certain medicines," adding that the levies could be applied to companies that have not struck trade agreements with the White House.

Trump has now moved ahead with the announcement, escalating trade tensions in the global pharmaceutical supply chain.

However, the brokerage had underlined that the policy impact on Indi...